Stay updated on Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial page.

Latest updates to the Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial page
- Check2 days agoChange DetectedA new revision entry v3.3.4 was added to the Study Record Versions in the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision history updated to include v3.3.3; the HHS Vulnerability Disclosure link and revision v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check52 days agoChange DetectedThe record history now shows a new revision entry v3.3.2, replacing the previous v3.2.0 entry.SummaryDifference0.1%

- Check59 days agoChange DetectedA government funding notice appears, warning that information may not be up to date and that transactions may not be processed, with links to cc.nih.gov and opm.gov for status updates.SummaryDifference0.8%

- Check73 days agoChange DetectedThe history shows multiple versions with updates to study status and recruitment across several dates, including a later entry in 2025. This indicates ongoing updates to the trial record.SummaryDifference0.1%

- Check102 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference13%

Stay in the know with updates to Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pyrotinib Adjuvant Study in HER-2+ Breast Cancer Clinical Trial page.